Armenian central bank’s interventions amount to $100 million

YEREVAN, October 31. /ARKA/. Armenia’s Central Bank’s intervention in the local foreign exchange market since the beginning of the year has amounted to $100 million so far, Arthur Javadyan, chairman of the Central Bank, told journalists on Monday.

“We continue the policy of a floating exchange rate, and since the beginning of the year we have poured more than $100 million in dram equivalent into the economy. We bought currency in the market contributing to economic growth and inflation in order to prevent deflation,” Javadyan said.

He noted that the Central Bank did not allow excessive revaluation of the national currency in order to exclude its subsequent possible negative impact, including on Armenian exports.

Javadyan said also that inflation will not exceed 2% by the end of 2017. According to him, at the moment, the 12-month inflation is 1.7%, which is very low, and by the end of 2017 it will grow to 2.5%-2.6%, which is also not a threat to the economy.

“The low inflationary environment is the best factor for ensuring stable economic growth. We have low inflation, which corresponds to the best world standards, and in comparison with other countries of the region the situation in Armenia is quite successful,” Javadyan said, saying that in Azerbaijan inflation at the moment is already 13%. -0-

spot_img

POPULAR

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

An Armenian Business Founded in a Garage: Games for Live Communication with the Support of Acba Bank

The success story of board games created by David Hovhannisyan began in a small garage near his home. David and his friends created educational games during their student years; as the number of orders grew, they decided to expand the business.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

LATEST NEWS

spot_imgspot_imgspot_img